
Anixa Biosciences Inc, a cancer-focused biotechnology company, is engaged in harnessing the body's immune system in the fight against cancer. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. It is devel... Anixa Biosciences Inc, a cancer-focused biotechnology company, is engaged in harnessing the body's immune system in the fight against cancer. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. It is developing the CchekTM platform, a series of inexpensive non-invasive blood tests for early detection of solid tumours which is based on the body's immune response to the presence of a malignancy. The company is also developing chimeric antigen receptor T-cell (CAR-T) based immuno-therapy drugs that genetically engineer patient's own immune cells to fight cancer. Show more
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.19 | -6.62020905923 | 2.87 | 3.01 | 2.63 | 47489 | 2.83018114 | CS |
4 | -0.35 | -11.5511551155 | 3.03 | 3.2994 | 2.63 | 99984 | 3.03133524 | CS |
12 | -0.1589 | -5.59723836697 | 2.8389 | 3.2994 | 2.07 | 114240 | 2.76791073 | CS |
26 | -0.41 | -13.2686084142 | 3.09 | 4.2 | 2.07 | 98363 | 3.03371947 | CS |
52 | -0.53 | -16.5109034268 | 3.21 | 4.2 | 2.07 | 100202 | 3.031553 | CS |
156 | -0.08 | -2.89855072464 | 2.76 | 6.45 | 2.07 | 94812 | 3.67495921 | CS |
260 | 0.48 | 21.8181818182 | 2.2 | 8.09 | 1.33 | 189320 | 3.66009489 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales